Table 2.
Characteristics of active (non-attrition) and non-active (attrition) adolescents aged 10–19 years in 10 TASO centres (n=1228)
| Active (n=792) | Non-active (n=436) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % of total sample | Male | Female | n | % of total sample | Male | Female | P | |
| Site of participant | 0.000 | ||||||||
| Entebbe | 83 | (8) | 32 | 51 | 20 | (10) | 13 | 7 | |
| Gulu | 65 | (6) | 21 | 44 | 32 | (16) | 11 | 21 | |
| Jinja | 95 | (9) | 44 | 51 | 4 | (2) | 2 | 2 | |
| Masaka | 133 | (13) | 45 | 88 | 37 | (18) | 13 | 24 | |
| Mbale | 125 | (12) | 48 | 77 | 38 | (19) | 23 | 15 | |
| Mbarara | 119 | (12) | 55 | 64 | 12 | (6) | 5 | 7 | |
| Masindi | 32 | (3) | 18 | 14 | 30 | (15) | 10 | 20 | |
| Rukungiri | 126 | (12) | 61 | 65 | 5 | (2) | 2 | 3 | |
| Soroti | 127 | (12) | 60 | 67 | 1 | (0) | 0 | 1 | |
| Tororo | 121 | (12) | 55 | 66 | 23 | (11) | 13 | 10 | |
| Age (years) | 0.023 | ||||||||
| 10–14 | 641 | (62) | 297 | 344 | 109 | (54) | 53 | 56 | |
| 15–19 | 385 | (38) | 142 | 243 | 93 | (46) | 39 | 54 | |
| Highest level of education | 0.005 | ||||||||
| None | 193 | (19) | 86 | 107 | 30 | (15) | 18 | 12 | |
| Primary | 752 | (73) | 319 | 433 | 142 | (60) | 59 | 83 | |
| Secondary and above | 81 | (9) | 34 | 47 | 30 | (15) | 15 | 25 | |
| Venue of ARV refill | 0.670 | ||||||||
| CDDP | 631 | (65) | 277 | 354 | 121 | (60) | 56 | 65 | |
| Health facility | 395 | (35) | 162 | 233 | 81 | (40) | 36 | 45 | |
| Marital status | 0.007 | ||||||||
| Single | 983 | (84) | 426 | 557 | 165 | (82) | 8 | 7 | |
| Married | 43 | (12) | 13 | 30 | 10 | (6) | 84 | 103 | |
| CD4 at ART initiation | |||||||||
| <250 cells/mm3 | 694 | (68) | 28 | 397 | 157 | (78) | 68 | 89 | 0.005 |
| ≥250 cells/mm3 | 332 | (32) | 142 | 190 | 45 | (22) | 24 | 21 | |
| Year of ART initiation | |||||||||
| 2006–2008 | 366 | (36) | 174 | 192 | 87 | (43) | 36 | 51 | 0.046 |
| 2009–2011 | 660 | (64) | 265 | 395 | 115 | (57) | 56 | 59 | |
| WHO stage (n=984) | n=837 | n=167 | |||||||
| Stage 1&2 | 626 | (64) | 259 | 367 | 118 | (58) | 49 | 50 | 0.161 |
| Stage 3 | 177 | (18) | 69 | 108 | 42 | (21) | 16 | 25 | |
| Stage 4 | 34 | (3) | 20 | 14 | 7 | (3) | 1 | 6 | |